EisaiEisai Co., Ltd.4523東証プライム医薬品FY ending Mar 2024, consolidated, IFRS

Eisai revenue and profit

Out of every ¥100 of sales, about ¥7 is left as operating profit. Revenue changed -0.4% from the prior year, operating profit +33.4%.

Five-year trend

Revenue¥741.8B
FY ending Mar 2018: ¥600.1B¥600.1BFY ending Mar 2019: ¥642.8B¥642.8BFY ending Mar 2022: ¥756.2B¥756.2BFY ending Mar 2023: ¥744.4B¥744.4BFY ending Mar 2024: ¥741.8B¥741.8BFY18FY19FY22FY23FY24
Operating income¥53.4B
FY ending Mar 2018: ¥77.2B¥77.2BFY ending Mar 2019: ¥86.2B¥86.2BFY ending Mar 2022: ¥53.8B¥53.8BFY ending Mar 2023: ¥40B¥40BFY ending Mar 2024: ¥53.4B¥53.4BFY18FY19FY22FY23FY24
Operating margin7.2%
FY ending Mar 2018: 12.9%12.9%FY ending Mar 2019: 13.4%13.4%FY ending Mar 2022: 7.1%7.1%FY ending Mar 2023: 5.4%5.4%FY ending Mar 2024: 7.2%7.2%FY18FY19FY22FY23FY24

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin5.7%
Asset turnover0.56×
ROA3.2%
ROA3.2%
Financial leverage1.48×
ROE4.7%

Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin5.7%
2019: 9.9%9.9%2024: 5.7%5.7%1819222324
Asset turnover0.56×
2019: 0.61×0.61×2024: 0.56×0.56×1819222324
ROA3.2%
2018: 4.9%4.9%2019: 6.0%6.0%2022: 3.9%3.9%2023: 4.4%4.4%2024: 3.2%3.2%1819222324
Financial leverage1.48×
2019: 1.63×1.63×2024: 1.48×1.48×1819222324
ROE4.7%
2019: 9.7%9.7%2024: 4.7%4.7%1819222324
PeriodNet marginAsset turnoverROAFinancial leverageROE
2018——×4.9%—×—
20199.9%0.61×6.0%1.63×9.7%
2022——×3.9%—×—
2023——×4.4%—×—
20245.7%0.56×3.2%1.48×4.7%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Income statement (JPY millions)

ItemFY ending Mar 2018FY ending Mar 2019FY ending Mar 2022FY ending Mar 2023FY ending Mar 2024
Revenue600,054642,834756,226744,402741,751
Cost of revenue—————
Gross profit—————
SG&A—————
Operating income77,21286,15453,75040,04053,408
Pretax income—————
Income tax—————
Net income attributable to owners51,84563,38647,95455,43242,406
Operating margin12.9%13.4%7.1%5.4%7.2%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

ItemFY ending Mar 2018FY ending Mar 2019FY ending Mar 2022FY ending Mar 2023FY ending Mar 2024
Cash and equivalents¥270.5B¥291.9B¥309.6B¥267.4B¥304.7B
Total assets¥1.05T¥1.07T¥1.24T¥1.26T¥1.39T
Net assets—¥652B——¥899B

Sources

Show source documents (4)
  • EDINET (FSA Japan)

    有価証券報告書-第114期(2025/04/01-2026/03/31)

    ID S100YB052026-06-12Open
  • EDINET (FSA Japan)

    有価証券報告書-第111期(2022/04/01-2023/03/31)

    ID S100R09Z2023-06-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第110期(令和3年4月1日-令和4年3月31日)

    ID S100O9U72022-06-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第109期(令和2年4月1日-令和3年3月31日)

    ID S100LKNM2021-06-18Open

Extracted from XBRL: 11 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.